Landaas & Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$920K Buy
4,955
+53
+1% +$9.84K 0.22% 33
2025
Q1
$1.03M Hold
4,902
0.28% 22
2024
Q4
$871K Buy
4,902
+200
+4% +$35.5K 0.24% 25
2024
Q3
$928K Hold
4,702
0.26% 22
2024
Q2
$806K Buy
4,702
+184
+4% +$31.5K 0.25% 21
2024
Q1
$823K Sell
4,518
-885
-16% -$161K 0.27% 22
2023
Q4
$838K Buy
5,403
+536
+11% +$83.1K 0.31% 20
2023
Q3
$725K Hold
4,867
0.31% 19
2023
Q2
$656K Sell
4,867
-170
-3% -$22.9K 0.29% 24
2023
Q1
$803K Sell
5,037
-200
-4% -$31.9K 0.39% 18
2022
Q4
$846K Sell
5,237
-275
-5% -$44.4K 0.47% 14
2022
Q3
$740K Sell
5,512
-37
-0.7% -$4.97K 0.47% 16
2022
Q2
$850K Buy
5,549
+70
+1% +$10.7K 0.52% 15
2022
Q1
$742K Hold
5,479
0.39% 21
2021
Q4
$742K Hold
5,479
0.39% 21
2021
Q3
$591K Hold
5,479
0.34% 25
2021
Q2
$617K Sell
5,479
-100
-2% -$11.3K 0.35% 27
2021
Q1
$604K Buy
5,579
+250
+5% +$27.1K 0.36% 26
2020
Q4
$571K Hold
5,329
0.39% 24
2020
Q3
$467K Sell
5,329
-6,152
-54% -$539K 0.35% 25
2020
Q2
$1.13M Buy
11,481
+100
+0.9% +$9.82K 0.9% 13
2020
Q1
$935K Hold
11,381
0.79% 13
2019
Q4
$1.01M Sell
11,381
-436
-4% -$38.6K 0.7% 15
2019
Q3
$895K Sell
11,817
-78
-0.7% -$5.91K 0.65% 15
2019
Q2
$865K Sell
11,895
-194
-2% -$14.1K 0.62% 18
2019
Q1
$974K Buy
12,089
+111
+0.9% +$8.94K 0.7% 14
2018
Q4
$1.1M Sell
11,978
-91
-0.8% -$8.39K 0.91% 12
2018
Q3
$1.14M Buy
12,069
+8
+0.1% +$757 0.89% 12
2018
Q2
$1.12M Sell
12,061
-93
-0.8% -$8.61K 0.89% 11
2018
Q1
$1.15M Buy
12,154
+105
+0.9% +$9.94K 1.16% 10
2017
Q4
$1.17M Sell
12,049
-795
-6% -$76.9K 1.01% 10
2017
Q3
$1.14M Buy
+12,844
New +$1.14M 1% 10